BeOne Medicines President & COO Sells $106K in Stock

On August 25, 2026, Wu Xiaobin, the President and Chief Operating Officer of BeOne Medicines Ltd., executed a sale of company securities. The transaction involved the disposition of 280 American Depositary Shares (ADSs) at a price of $380.00 per share, resulting in a total transaction value of $106,400.

This sale was conducted under a Rule 10b5-1 trading plan, which was adopted by the reporting person on November 7, 2025. Such plans allow insiders to set up a predetermined schedule for buying or selling stocks at a future date, providing an affirmative defense against accusations of trading on non-public information.

Following the transaction, Mr. Wu's direct holdings in American Depositary Shares stand at 12,365. He also directly holds 1,270,084 Ordinary Shares and indirectly holds 4,000 ADSs through his wife. Each American Depositary Share represents 13 Ordinary Shares. The pre-planned nature of the sale and the substantial remaining holdings suggest this transaction is likely part of a personal financial management strategy rather than a change in outlook on the company's future.